` ENTX (Entera Bio Ltd) vs S&P 500 Comparison - Alpha Spread

ENTX
vs
S&P 500

Over the past 12 months, ENTX has underperformed S&P 500, delivering a return of -12% compared to the S&P 500's +14% growth.

Stocks Performance
ENTX vs S&P 500

Loading
ENTX
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ENTX vs S&P 500

Performance Gap Between ENTX and GSPC
HIDDEN
Show

Performance By Year
ENTX vs S&P 500

Loading
ENTX
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Entera Bio Ltd vs Peers

S&P 500
ENTX
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Entera Bio Ltd
Glance View

Market Cap
80.8m USD
Industry
Biotechnology

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. The firm conducts clinical trials on its proprietary technology, which allows oral delivery of large molecules and biologics while enhancing their absorption in the gastrointestinal (GI) tract. Entera Bio Ltd's technology addresses the major problems of oral drug delivery of large molecule active pharmaceutical ingredients (APIs). Most large molecules cannot be administered orally as they are not readily absorbed by the gastrointestinal tract and are rapidly degraded by a myriad of enzymes and acids in the gastrointestinal tract. The Company’s proprietary technologies act synergistically to transport and protect large molecules. The firm develops drugs for hypoparathyroidism, osteoporosis and bone healing.

ENTX Intrinsic Value
HIDDEN
Show
Back to Top